William West

Foley & Lardner LLP engages in the provision of legal services. Its practice areas include employee benefits and executive compensation, environmental, estates and trusts, finance, international tax and transfer pricing, private equity and venture capital, real estate, securities, commodities and exchange regulation, taxation, and transactions. The company was founded by Asahel Finch and William Pitt Lynde on September 8, 1842 and is headquartered in Milwaukee, WI.

Zielbio, Inc. develops a technology for identification of cancerous diseases. Its technology identifies high-value biomarkers of disease as well as companion targeting peptides capable of delivery of therapeutic payloads and as imaging agents. The company was founded by Kimberly A. Kelly, Gregory B. Fralish, Todd William Bauer in 2010 and is headquartered in Charlottesville, VA.

2020, Inc. offers eye care services. It also offers delivers on-site eye care and eye exams to businesses and their employees via a mobile eye clinic. The company was founded by Howard Bornstein in 2013 and is headquartered in Boston, MA.

Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA.

RWC Partners Ltd. provides investment advisory services. Its activities portfolio include convertible bonds, European equity, Japan active engagement, equity income, emerging and frontier market equity, and global horizon equity. The company was founded by Chris Simon Maude, John Hugh Innes, and Mark Robert Hadsley-Chaplin in 2000 and is headquartered in London, the United Kingdom.

James Hutton Ltd. provides agricultural support activities. The company offers pathogen testing, plant analysis, and consulting services. It works with companies interested in licensing technologies that the researchers use to come up with a variety of potatoes, soft fruits, barley, and other agricultural products. The company was founded in 1989 and is headquartered in Dundee, the United Kingdom.

Morningside Group (Morningside Group) is a venture capital and private equity firm founded in 1986 by Lok Chung Chan and Chi Chung Chan. The firm is headquartered in Hong Kong.

Biotechnology & Biological Sciences Research Council operates a funding agency for academic research and training. It funds bioscience, people and research infrastructure that helps to tackle major challenges such as the impact of climate change, a healthier old age, and sustainable food production, land use and energy production. The company is headquartered in Swindon, the United Kingdom.

Howard Sandcliffe Investments 6 Ltd. provides management consulting services. The private company is based in Cambridge, UK. and has subsidiaries in United Kingdom.

GreenLight Biosciences, Inc. engages in a biotechnology company.. It delivers attractive solution for production of chemicals and fuels from renewable resources, eliminating the need for petroleum feedstocks. The company was founded by Andrey J. Zarur, Marta Ortega-Valle, and James R. Swartz and is headquartered in Medford, MA.

Velcourt Ltd. manages and advises on farms throughout Europe. The firm is retained by landowners, tenants, working farmers and institutional investors. The company was founded in 1967 and is headqaurtered in Ledbury, The United Kingdom.

Part of Howard Ventures Ltd., Howard Developments Ltd. engages in developing and selling real estate properties. The company is based in Croydon, UK.

Part of John Innes Centre Ltd., John Innes Foundation is a charity founded in 1910 and based in Norwich, UK. The foundation is dedicated to advancing plant science, horticulture, and related subjects. The British company provides substantial support to the rotation PhD programme at the John Innes Centre and the Sainsbury Laboratory, which is renowned for its academic excellence and groundbreaking research attracting elite candidates from around the world. The company achieves this by supporting scientific research, education, training, and public engagement, as well as maintaining and exploiting a unique historical collection of books and other documents. The foundation's mission is to advance the acquisition and application of knowledge about plants and microbes for societal, environmental, and commercial benefit.

The James Hutton Institute engages in conducting research in environment, crop and food sciences. The firm focuses on crops, soils and land use and environmental research, and makes a contribution to the understanding of key global issues, such as food, energy and environmental security, and developing and promoting technological and management solutions. The company was founded on April 1, 2011 and is headquartered in Scotland, the United Kingdom.

Howard Ventures Ltd. provides commercial property development and management services. The private company is based in Cambridge, UK. and has subsidiaries in United Kingdom.

Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France.

The Aerospace Technology Institute (ATI) is a UK-based organization that creates technology strategies for the aerospace sector and funds research and development projects. The ATI is committed to managing and maintaining the UK Aerospace Technology Strategy and its associated funding streams. The private company is based in London, UK, and was founded in 2014. The British company has developed various tools, databases, and reports to support the aerospace industry. The ATI promotes transformative technology in air transport and funds world-class research and development. Gary Elliott has been the CEO of the company since 2014.

ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.

Howard Investment Co. Ltd. provides investment services. The private company is based in Cambridge, UK. and has subsidiaries in United Kingdom. Howard Investment Co. was founded in 2005.

Alms Therapeutics SAS provides research and development in the treatment of diabetes. The company was founded by Jason Robert Dinges on July 4, 2017 and is headquartered in Paris, France.

Apic Bio, Inc. engages in the development of treatment for neurological and liver diseases. It offers THRIVE, a platform that silences a mutant gene product and replaces a normal gene product in a single dual function vector. The company was founded by Robert H. Brown, Jr., John Reilly, and Christian Mueller in 2017 and is headquartered in North Cambridge, MA.

Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009.

Allysta Pharmaceuticals, Inc. operates as a biopharmaceutical company. The frim develops medicine for ophthalmology, particularly dry eye disease and glaucoma. The company was founded by Henry H. Hsu and is headquartered in San Mateo, CA.

Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland.

Founded in 2000, Howard Lewisham Ltd. is a commercial real estate investment and British management company. The company is based in Cambridge, UK. Part of Howard Investment Co. Ltd., the company provides services related to commercial real estate investment and management.

Founded in 2010, Howard Sawston Ltd. is a British company that engages in investment, management, and development of commercial properties. Part of Howard Investment Co. Ltd., the company is based in Cambridge, UK.

Founded in 1985, Howard Property Ltd. is a holding British company that operates through its subsidiaries to lease commercial property. The company is based in Cambridge, UK.

Part of Howard Investment Co. Ltd., Howard Grove Ltd. is a British company that provides investment and commercial property management services. The company is based in Cambridge, UK and was founded in 2001.

Part of Howard Investment Co. Ltd., Howard Regent Ltd. is a British company that provides investment and commercial property management services. The company is based in Cambridge, UK and was founded in 2008.

Part of Howard Investment Co. Ltd., Howard Bedford Ltd. is a British investment company that manages and develops commercial properties. The company is based in Cambridge, UK and was founded in 2014.

Part of Howard Investment Co. Ltd., Howard Crescent Ltd. functions as an investment holding British company. The company is based in Cambridge, UK and was founded in 2005.

Founded in 2015, Howard Cambridge Ltd. is a company that invests and manages residential properties. Part of Howard Investment Co. Ltd., the company is based in Cambridge, UK.

Founded in 2001, Howard Stansted Ltd. is a British company that engages in investment and management of commercial properties. Part of Howard Investment Co. Ltd., the company is based in Cambridge, UK.

Part of Howard Ventures Ltd., HPG Gonville Ltd. is a British company that buys and sells real estate properties. The company is based in Cambridge, UK and was founded in 2017.

Prilenia Therapeutics BV develops and manufactures pharmaceuticals. The company was founded in 2018 and is headquartered in Naarden, the Netherlands.

Cell Capital Partners LLP (Cell Capital) is a venture capital firm founded in 2020. The firm is headquartered in London, the United Kingdom.

Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million.

Adiso Therapeutics, Inc. creates medicines to treat inflammatory diseases with the goal of improving the lives of patients and their families. Adiso Therapeutics is based in Concord, MA. The company believes that current therapeutic approaches are often inadequate and can pose significant safety concerns for patients. Scott T. Megaffin has been the CEO of the company since 2022.

Plenary AI is a company that specializes in providing clinical staff with customized artificial intelligence tools to help them make more informed decisions for patients. The company is based in Gaithersburg, MD and was founded by Martin Pomper and Edward Herskovits. Plenary AI's team is led by world-class experts from leading biomedical research systems, including Johns Hopkins University and the University of Maryland Medical Center. The company's aim is to revolutionize precision health by combining relevant biomarkers and multi-modality imaging to put each patient's unique information against the backdrop of a vast amount of data analytics. Plenary AI has developed several products, including an automated screening, diagnostic, and prognostic assessment tool, a machine learning framework for cancer classification on PET images, and a machine learning framework for Parkinson's disease subtype selection. Edward Herskovits has been the CEO since incorporation.

NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands.